FDA's evaluation concluded that the criteria weighed against placement on the list, citing inadequate physicochemical characterization, immunogenicity concerns from impurities and aggregates, lack of clinical effectiveness data for any approved use, and absence of published human exposure data for the proposed subcutaneous and topical routes
We do recommend you contact your insurance company to find out what their requirements are, as they change all the time
Its important to follow certain rules to make sure the treatment is safe and works well
Thrombosis Research 2012 DOI Storage & handling + Store lyophilized at 20 C, desiccated and protected from light
Once you start supplementation, your body gets to work making new, healthy red blood cells
Its the same product used in different ways to treat different concerns